Dr. Colleen Stack, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $211.94 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $107.06 | 6 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $62.66 | 4 | $0 (2019) |
| EISAI INC. | $18.57 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.21 | 1 | $0 (2021) |
| GENZYME CORPORATION | $11.44 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $24.70 | 2 | Allergan, Inc. ($12.49) |
| 2020 | $61.41 | 4 | Allergan, Inc. ($61.41) |
| 2019 | $125.83 | 7 | Novartis Pharmaceuticals Corporation ($62.66) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/12/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/13/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/12/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/03/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2019 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/08/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 177 | 205 | $72,805 | $19,928 |
| 2022 | 7 | 140 | 159 | $55,490 | $15,842 |
| 2021 | 10 | 333 | 400 | $57,370 | $27,467 |
| 2020 | 14 | 614 | 786 | $119,184 | $54,378 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 53 | $26,235 | $7,001 | 26.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 27 | $18,225 | $4,328 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 31 | $8,060 | $2,864 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 23 | $7,705 | $2,154 | 28.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 31 | $5,580 | $1,843 | 33.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 21 | 22 | $3,850 | $955.90 | 24.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 18 | 18 | $3,150 | $782.10 | 24.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 41 | $20,295 | $6,125 | 30.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 20 | 21 | $14,175 | $3,547 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 34 | $6,120 | $1,865 | 30.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 23 | $5,980 | $1,816 | 30.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,020 | $1,246 | 31.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 14 | 15 | $2,625 | $664.95 | 25.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 13 | 13 | $2,275 | $577.14 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 181 | $28,055 | $16,240 | 57.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $10,578 | $4,852 | 45.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 39 | $4,173 | $2,189 | 52.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $5,248 | $1,690 | 32.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $2,976 | $1,459 | 49.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 17 | 18 | $1,566 | $271.44 | 17.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 22 | 23 | $1,472 | $242.88 | 16.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 14 | 14 | $1,232 | $235.20 | 19.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 24 | 25 | $1,450 | $194.25 | 13.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 27 | 31 | $620.00 | $93.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 166 | 304 | $47,120 | $24,707 | 52.4% |
About Dr. Colleen Stack, MD
Dr. Colleen Stack, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Pollocksville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1245659226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Colleen Stack, MD has received a total of $211.94 in payments from pharmaceutical and medical device companies, with $24.70 received in 2021. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($211.94).
As a Medicare-enrolled provider, Stack has provided services to 1,264 Medicare beneficiaries, totaling 1,550 services with total Medicare billing of $117,615. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Pollocksville, NC
- Active Since 04/07/2014
- Last Updated 07/03/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1245659226
Products in Payments
- BOTOX (Biological) $107.06
- AIMOVIG (Biological) $47.46
- Fycompa (Drug) $18.57
- GILENYA (Drug) $15.20
- TRINTELLIX (Drug) $12.21
- AUBAGIO (Drug) $11.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.